Delivery Order SPE2DB22D3011-SPE2DB24FQ3KB
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,576.98 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a medical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.30 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a medication. The contract has a period of performance through May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,950.38 Firm Fixed Price Delivery Order contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of EMGALITY 120 MG/ML PENML, a medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,108.36 and is a Firm Fixed Price Delivery Order that runs through January 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product EMGALITY 120 MG/ML PENML, with a ceiling value of $1,218.84 and a period of performance through May 23, 2025. The contract has a firm-fixed-price pricing type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,296.75 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $1,671.20 and an ultimate completion date of August 9, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its corporate office division, will provide the medication to...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,037.40 and covers the delivery of EMGALITY 120MG/ML 1S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,618.54 firm fixed-price delivery order is for EMGALITY 120 MG/ML PENML, with a period of performance through November 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.64 firm-fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a medication. The contract has a period of performance through March 12, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...